| Phase 3 |
| NCT06911502 |
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab… |
Follicular Lymphoma |
Recruiting |
| NCT06356129 |
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus… |
Large B-cell Lymphoma |
Active, Not Recruiting |
| Phase 2 |
| NCT06834373 |
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive… |
Large B-Cell Lymphoma With IRF4 Rearrangement |
Recruiting |
| NCT05283720 |
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC)… |
Non-Hodgkin Lymphoma |
Recruiting |
| NCT06271057 |
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High… |
Diffuse Large B-cell Lymphoma Refractory |
Recruiting |
| NCT06425302 |
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab… |
Lymphoma, Follicular |
Active, Not Recruiting |
| NCT06108232 |
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High… |
Follicular Lymphoma |
Active, Not Recruiting |
| Phase 1/2 |
| NCT07018752 |
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas |
Peripheral T Cells Lymphoma (PTCL) |
Recruiting |
| NCT03930953 |
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With… |
Lymphoma, Non-Hodgkin |
Active, Not Recruiting |
| NCT06035497 |
A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369… |
Relapsed or Refractory T-cell Lymphomas |
Active, Not Recruiting |
| NCT07578077 |
Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or… |
Recurrent Mantle Cell Lymphoma |
Not Yet Recruiting |
| Phase 1 |
| NCT06209619 |
CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma |
B-Cell Non-Hodgkin Lymphoma-Recurrent |
Recruiting |
| NCT05169515 |
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or… |
Non-Hodgkin Lymphoma |
Recruiting |
| NCT04884035 |
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to… |
Lymphoma, B-Cell |
Recruiting |
| NCT07608731 |
Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS… |
Large B-cell Lymphoma |
Not Yet Recruiting |